ECRM_1170x120_8-1-17

Senate Special Committee on Aging

NCPA urges more scrutiny of generic drug pricing

NCPA urges more scrutiny of generic drug pricing

ALEXANDRIA, Va. — In tandem with a congressional hearing, the National Community Pharmacists Association called on lawmakers to take a closer look at recent generic drug price hikes and their impact on patients and community pharmacists. On Wednesday, the Senate Special Committee on Aging held a hearing titled “Sudden Price Spikes in Off-Patent Drugs: Perspectives

Senators launch investigation of Rx pricing

Senators launch investigation of Rx pricing

WASHINGTON — A U.S. Senate committee has begun a probe of recent spikes in pharmaceutical pricing. Sens. Susan Collins (R., Maine) and Claire McCaskill (D., Mo.), who lead the Senate Special Committee on Aging, on Wednesday said the bipartisan investigation will include hearings, with the first slated for next month. The lawmakers noted that the

Senate report calls for higher generics usage

WASHINGTON — Providing incentives to prescription drug plan sponsors that increase generic drug use is among recommendations that the Senate Special Committee on Aging unveiled last month in a bipartisan report that focuses on ways to increase the utilization of generics within the Medicare Part D program. The panel also heard about industry issues beyond